The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Clinical Research of Hemoperfusion Combined with Hemodiafiltration in Treatment of Renal Osteitis Fibrosa Induced by Uremia
Author(s): 
Pages: 75-78
Year: Issue:  5
Journal: Clinical Misdiagnosis & Mistherapy

Keyword:  血液灌流血液透析滤过血液透析肾性纤维性骨炎尿毒症继发性甲状旁腺功能亢进;
Abstract: 目的 比较传统血液透析(hemodialysis,HD)和血液灌流(hemoperfusion,HP)串联血液透析滤过(hemodiafiltration,HDF)治疗尿毒症并发肾性纤维性骨炎的疗效.方法 选择我院2009年10月-2011年10月慢性肾功能衰竭尿毒症期并发肾性纤维性骨炎患者40例,随机分为A、B两组.A组予传统HD,B组予HP串联HDF,分别于首次治疗前后及治疗12周前后测定甲状旁腺素(parathyroid hormone,PTH)、成纤维细胞生长因子23(fibroblast growth factor 23,FGF23)、骨碱性磷酸酶(bone alkaline phosphatase,BALP)、血钙、血磷,分析各指标及相关临床症状改善情况.结果 两组患者首次治疗前PTH、FGF23、BALP、钙、磷及骨痛、顽固性皮肤瘙痒评分比较差异均无统计学意义(P>0.05),首次治疗后PTH、FGF23、BALP、钙、磷比较差异有统计学意义(P<0.05);末次治疗前PTH、FGF23、BALP及骨痛、顽固性皮肤瘙痒评分比较差异有统计学意义(P<0.05);末次治疗后PTH、FGF23、BALP、钙、磷比较差异有统计学意义(P<0.05).结论 HP串联HDF能有效改善尿毒症肾性纤维性骨炎.
Related Articles
loading...